Your browser doesn't support javascript.
loading
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.
Andersson, E; Kuusanmäki, H; Bortoluzzi, S; Lagström, S; Parsons, A; Rajala, H; van Adrichem, A; Eldfors, S; Olson, T; Clemente, M J; Laasonen, A; Ellonen, P; Heckman, C; Loughran, T P; Maciejewski, J P; Mustjoki, S.
Afiliación
  • Andersson E; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Kuusanmäki H; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Bortoluzzi S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Lagström S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Parsons A; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Rajala H; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • van Adrichem A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Eldfors S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.
  • Olson T; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Clemente MJ; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Laasonen A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Ellonen P; University of Virginia Cancer Center, University of Virginia, Charlottesville, VA, USA.
  • Heckman C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Loughran TP; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Maciejewski JP; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Mustjoki S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Leukemia ; 30(5): 1204-8, 2016 05.
Article en En | MEDLINE | ID: mdl-26419508
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación Missense / Factor de Transcripción STAT3 / Leucemia Linfocítica Granular Grande Límite: Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mutación Missense / Factor de Transcripción STAT3 / Leucemia Linfocítica Granular Grande Límite: Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido